July 26,2010

NovImmune enters exclusive antibody licensing agreement with Genentech

June 30,2010

Aravis Energy in the Swiss Press - Handelszeitung, 30 June 2010

June 29,2010

Omeros Successfully Unlocks Orphan GPCRs
Opportunity for Development of Unprecedented Number of Novel Drug Targets

June 14,2010

Evolva Article in Roche Magazine RoSearch April 2010

June 9,2010

S*BIO Completes Enrollment of Patients in Phase 2 Clinical Trials for its JAK2 Inhibitor SB1518

May 13,2010

Initial public offering of shares of common stock of Ikaria, Inc

May 4,2010

Aravis sells wind farm to Swiss utility company EBM

May 4,2010

S*Bio and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors

May 4,2010

Evolva announces Board nominations

May 3,2010

Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery

April 14,2010

Synosia Therapeutics' SYN-115 Improves Motor and Non-Motor Function in Patients
with Mild- to-Moderate Parkinson's Disease

April 9,2010

Erste Offshore-Fonds Repatriierung einer Risikokapital Gesellschaft mit „Limited Partnership"-Struktur von der FINMA bewilligt

March 31,2010

Omeros reports Phase 2 data showing multiple clinical benefits in patients undergoing Arthroscopic Meniscectomy Surgery

March 30,2010

Ikaria® acquires new drug application for Lucassin®

March 11,2010

Evolva participants in food ingredient research initiative

March 9,2010

Omeros Licenses PDE7 Compounds for Parkinson's Disease Program

February 1,2010

Synosia Announces Positive Interim Results for Potential First-in-Class Treatment for Parkinson's Disease

January 4,2010

Evolva enters discovery collaboration with Roche

© 2008 Aravis SA  |  Lehfrauenweg 10   |  CH 8053 Zuerich  |  Tel. +41 43 499 20 00 | Fax +41 43 499 20 01  |  Disclaimer  |   Developed by Dogbytes Websolutions